chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient felt anxious, cold , pale . She felt her blood pressure is up ,and felt shaky. I checked her blood pressure was 138/93 .
This spontaneous report as received from a certified medical assistant (C.M.A.) refers to multiple unspecified patients of an unknown age and gender. Medical history and concurrent conditions were not reported. On multiple unknown dates (ranging from December 2014, January 2015, and February 2015), the patients were vaccinated with doses of improperly stored (MMR II (lot# K003823, expiration date 14-MAR-2016, dose and route of administration were not reported). Concomitant medication was not reported. No adverse effects were reported. Product quality complaint (PQC) was not involved. Additional information has been requested.
For 8 days: heavy fatigue, headache,  For 3 days: rash For 5 days: nausea
One day post vax pt presented to physician with 104 temperature and rash covering arms, legs and face. Physician state not to allow pt to continue with DTAP/ DT only.
consumer received MMRV and VARIVAX concomitantly; VARIVAX administered by IM route; This spontaneous report was received from a nurse referring to a 31-year-old male patient. The patient's concurrent conditions, relevant medical history and concomitant medications were not provided.    On 21-AUG-2020 the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) (Dosage regimen; lot and expiration date were not reported) administered intramuscularly (IM) (Incorrect route of product administration) for prophylaxis.  On 24-AUG-2020, the patient returned to clinic with no complaints; and on an unspecified date in August 2020, he was vaccinanted with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (manufacturer unknown) (Dosage regimen; lot and expiration date were not reported) for prophylaxis. On 27-AUG-2020, it was identified that the patient was vaccinated concomitantly with both vaccines (inappropriate schedule of product administration).
hot; hard; the injection site was red; injection site was about the size of quarter (circumference).; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (the injection site was red), VACCINATION SITE SWELLING (injection site was about the size of quarter (circumference).), VACCINATION SITE WARMTH (hot) and VACCINATION SITE INDURATION (hard) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (the injection site was red) and VACCINATION SITE SWELLING (injection site was about the size of quarter (circumference).). On 30-Jan-2021, the patient experienced VACCINATION SITE WARMTH (hot) and VACCINATION SITE INDURATION (hard). At the time of the report, VACCINATION SITE ERYTHEMA (the injection site was red), VACCINATION SITE SWELLING (injection site was about the size of quarter (circumference).), VACCINATION SITE WARMTH (hot) and VACCINATION SITE INDURATION (hard) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        No relevant concomitant medications were reported.  Treatment for the events was not reported.
Swelling in throat, lips, fast heartbeat, dizziness, bloodshot eyes. Difficulty breathing unless head held back to open esophagus.
Couldn't lay on her left side / arm was so sore; Couldn't get out of bed for 2 days/Couldn't lay on her left side; This case was reported by a pharmacist via other manufacturer and described the occurrence of pain in arm in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In November 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced pain in arm and mobility decreased. On an unknown date, the outcome of the pain in arm and mobility decreased were recovered/resolved.   It was unknown if the reporter considered the pain in arm and mobility decreased to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix and had pain in arm and could not lay on left side. The patient said when she had vaccine, she could not get out of bed for 2days. This case linked with US2021AMR020911, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR020911:Same reporter.
improperly stored vaccine was administered; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 25-JAN-2021, the patient was vaccinated with an improperly stored dose of hepatitis b vaccine (recombinant) (thimerosal free) (RECOMBIVAX HB) 1 injection, (lot # T004378, expiration date reported as 31-OCT-2022, but upon internal validation stablished as 01-NOV-2022 (dose, route of administration and anatomical location were not reported) for prophylaxis. The administered dose of vaccine was stored in the temperature of above 9 degrees Celsius (13.4 degrees Celsius) for 2 hours and 9 minutes. There were no previous temperature excursions reported. The improper storage was recorded by digital data logger.  This is one of multiple reports from the same reporter.; Sender's Comments:  US-009507513-2101USA013389: US-009507513-2101USA013543: US-009507513-2101USA013730: US-009507513-2102USA000172: US-009507513-2102USA000195: US-009507513-2102USA000219:
Redness, swelling at itching at vaccine site, persisting at 13 days after vaccine given. Generalized itchy macular papular rash - treated w/IM KENALOG, oral Prednisone and BENADRYL.
have redness around the injection site; it feels hot; little bit hard; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (have redness around the injection site), VACCINATION SITE WARMTH (it feels hot) and VACCINATION SITE INDURATION (little bit hard) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (have redness around the injection site), VACCINATION SITE WARMTH (it feels hot) and VACCINATION SITE INDURATION (little bit hard). At the time of the report, VACCINATION SITE ERYTHEMA (have redness around the injection site), VACCINATION SITE WARMTH (it feels hot) and VACCINATION SITE INDURATION (little bit hard) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Within 24 hours of first GARDASIL shot pt got rash all over her torso. She had raised bumps that are very itchy. Physician gave her steroid medpack w/o help. This continued for over 3 weeks. She still has itchy rash only on torso.
PAIN THROUGHOUT BODY, ESPECIALLY EYES AND HEAD. NO ENERGY, DRY MOUTH
About 2 hours after receiving the COVID shot, while seated in my recliner, watching TV, I began to feel a sickened feeling with tightness in my chest and heart area.  The sensation lasted for about 15 minutes then completely subsided.  About 4 hours later upon retiring to bed before falling asleep, I began to experience a abnormal sound in both my ears.  I covered my ears and the sound remained unchanged.  I do suffer tinnitus and am used to ringing in my ears.  This was more of a rushing metallic sound similar to the rushing water but high pitched and metallic.  This anomaly lasted for around 30 minutes.
abdominal pain, orange urine, jaundice, auto immune hepatitis: in hospital for week
Patient reports numbness and tingling of bilateral upper extremities that began 4 days post vaccination. Occasional lip tingling. Day of vaccination mild discomfort at injection site and headache. Resolved. No other systemic symptoms. On exam afebrile individual who is neurologically intact. Sensation, range of motion, and strength in all cervical dermatomes/myotomes intact. Given history of B12 deficiency, recommended screening with PCP. No other recent cervical trauma, no history of vaccine reactions, no history of neurologic conditions. Scheduled to follow-up and see if symptoms resolve or can be attributed to another condition besides vaccine reaction, since this is currently not known as a vaccine side effect in the research data provided by Moderna.
Pt experienced an injection site reaction characterized by a swollen and reddened shoulder. Pt was treated with Tagamet and Benadryl.
This spontaneous (non-serious) report received from a patient, concerned a female of unspecified age. The patient's height and weight not reported. No past medical history, concomitant medications or concurrent conditions reported. The patient received COVID-19 vaccine ad26.cov2.s (suspension for injection, batch/lot# and expiry: unknown), route of admin and dose not reported, administered Apr 2021, for immunization. On an unspecified date, patient experienced headache; with outcome of not reported. The action taken with COVID-19 vaccine ad26.cov2.s: not applicable. Per procedure, no follow-up will be requested for this case. This case, from the same reporter is linked to 20210946560.
No adverse event; First dose on 9-JAN-2021 and second dose on 1-FEB-2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 9-JAN-2021 and second dose on 1-FEB-2021) and NO ADVERSE EVENT (No adverse event) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 028L20A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 9-JAN-2021 and second dose on 1-FEB-2021). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 9-JAN-2021 and second dose on 1-FEB-2021) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            Patient administered the vaccine at a clinic.  It was unknown if  patient received any other vaccines within 4 weeks prior to the COVID-19 vaccine administration.  Patient administered 3rd dose of Moderna COVID-19 vaccine on 05-Nov-2021, Batch/Lot no. 032F21A.  Patient administered 4th dose of Pfizer Bivalent vaccine on 30-Sep-2022, Batch no. GJ6742 via Intramuscular route.  No concomitant medication reported. No treatment medication reported.
The vaccine expired past the 30-day recommendation. At this time there have been no s/s of any adverse event
The pt had a Pfizer booster on 1/6. On 1/8 she developed top L side lip swelling. No other symptoms
pt devel fever of 102 reported by mom 2 days p/vax; mom giving APAp to pt every 6hrs @ home x 2 days; visit to MD 19AUG95 T102 R; APAP given;
L arm swollen and warm Sat AM. Blisters Sunday, bursted Mon T-"little," now rash (scab) on arm. Tylenol Tx for pain an dtemp remains swollen and warm.
Arm & neck pain starting one day post-vaccine - progressing to headache body ache, heartburn, general malaise.
Initial health authority report (PEI2010009699) received on 27 Apr 2010: This smoker patient was vaccinated with RABIPUR (batch number 453011A) on 25 Feb 2010 at 8.00 hrs. 10 hours after vaccination, the patient presented with stomach cramp and chills and 14 hours after vaccination, the patient presented with breathlessness and distress respiratory. The patient did not hospitalize. Outcome of the event was reported as complete recovery.
Pt received flu vax on 10/19/00. She expired in her sleep on 10/20/00.
In the emergency department, patient was found to be in DKA.  He was started on insulin drip.  Patient tested positive for covid.   Inflammatory markers are elevated.  Chest x-ray consistent with bilateral infiltrates. Patient diagnosed with covid-19 pneumonia. Patient remained on room air. Patient was discharged home.
On 10/15/13 given flu vaccine in (R) arm at Primary Care Office. Patient states within several hours had severe pain in (R) lower upper arm and swelling of arm, itching mild at site. Patient used BENADRYL and ADVIL on 10/16/13 with decreased swelling. Seen in clinic on 10/18/13 due to redness and pain injection site at (R) bicep not deltoid area. Improving at time of visit no functional or sensory deficit or signs of injection on exam. Advise treated with ice/ADVIL/elevation.
Fatigue, achy muscles, fever warmth, a general feeling of weakness.  Some fuzziness in my head.  Drinking water and taking ADVIL.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. There was no information about the patient's concomitant medications, allergies and pertinent medical history reported. On 26-JUL-2016, the patient was vaccinated with improperly stored MMR II lot # L029266, therapy type (dose, strength, route of administration and expiry date were not reported). This is one of several reports received from the same reporter. Additional information has been requested.
tingling in her tongue, chest tightness. Given 10ml Benadryl   Tingling and tightness subsided left with HR 75 BP: 130/80
After second shot I developed pain in my upper arms and shoulders.  By the end of the month I was in serious pain and often unable in the morning to use my arms.  Saw primary care doctor first week of March who diagnosed Polymyalgia Rheumatica PMR and immediately put me on prednisone which helped a lot after a few days.  But it caused lots of other problems including diabetes 2, skin issues and infections, LACK of immune system, fatigue, and more.  I even GOT Covid 19 in fall and was hospitalized for 5 days including pneumonia.  Am still having to use methylprednisolone to control the PMR so still have side effects from it.  Have succeeded in tapering to 4 mg a day but its very difficult to get off pred, and I am tired of being sick.
Swelling, redness, itching/stinging, rash-like on upper left arm started small on 08/06/11 and on 08/08/11 is approximately 8 inches long and 3 inches wide.
This spontaneous report was received from a 70 year old female patient with diabetes, high blood pressure, high cholesterol and erythromycin allergy who was reporting on herself. On 12-NOV-2012 the patient was vaccinated with a dose of ZOSTAVAX injection (route, strength, lot number and expiration date not provided). Concomitant therapies included ATIVAN, ACTOS, BENICAR, CRESTOR, LEXAPRO and LANTUS. On 30-DEC-2013 the patient developed a rash and pain after receiving the ZOSTAVAX vaccine. The patient reported that this rash developed on her neck, right shoulder, right arm and all the way down to her right hand and thumb. The patient then reported that on 30-DEC-2013 she has lost almost all of the mobility in her right hand and right arm. The patient reported that she can't lift any thing with her right arm. The patient saw the doctor. The outcome of events was not reported. The relatedness between vaccination with ZOSTAVAX and events was not reported. Upon internal review the event of patient's decreased mobility was considered to be disabling. Additional information has been requested.
My mother who is also my babysitter for my 9 month old daughter received the shingles vaccination on or about 12/1/2012. She is 58 years old. She is in constant contact with my daughter at least 4-5 days a week and is a very loving grandmother which means lots of cuddles and kisses. On 12/28/2011-12/29/2011 we noticed our daughter becoming fussy, slight fever, runny nose, not sleeping as well. Thought it's teething or a cold. On 12/31/2011 we noticed 3 small bumps on her neck area. Between 1/1 and 1/2/2012 more bumps followed on her forehead. By the night of 1/2/2012 the older bumps were becoming fluid filled and new ones had spread throughout body. On 1/3/2012 we took her to the pediatrician who confirmed what I expected. It was chicken pox. My daughter is not in daycare, we do not attend large gatherings, she does not get passed around to many people due to stranger anxiety. The doctor told us this is the first case she has seen of chicken pox in a very long time. She even asked if anyone close had the shingles or the vaccine. I was unaware at the time my mom had this vaccine on the above date, and my dad -also close to my child- had the vaccine just 2 weeks before my mother.
Burning and pain at the site. I also had the pain shoot from my left deltoid up to the side of my left neck. I had to apply a cold rag for the burning.
1:40 PM client received 3 vaccines 1st Dtap and polio in LA, MMR #2 placed in RA. 3 to 5 minutes after receiving shots client became pale, started vomiting and had local reaction redness to RA (MMR injection site). Client laid on bed, legs elevated, cold compress placed on forehead. Client took several swallows of coke cola. No difficulty breathing or swallowing noted. BP checked at 2:15 pm 90/58, color returned to face client walking around.
severe chills, joint aches , confusion,  Next day, 1/1/21,  fully recovered with no side effects
This case was reported by a healthcare professional and described the occurrence of hepatitis B antigen positive in a female subject aged between 50 and 59 years old was vaccinated with Engerix-B (GlaxoSmithKline). Concurrent medical conditions included hemodialysis. On either 02 January 2007 or 03 January 2007, the subject received "possibly the 3rd last dose" of the Engerix-B series. On an unspecified date after 02 January 2007 or 03 January 2007 and before 23 January 2007, 1 week after  vaccination with Engerix-B, the subject tested positive for hepatitis B antigens. The outcome of the event was not reported.
Patient reported pain in the vaccine arm. Came in 7-24-21 with no more pain, but arm was red and inflamed. He stated it was warm to the touch. Red area extended from site of vaccination in shoulder to near the elbow.
Information has been received from a licensed practical nurse concerning a 7 year old female student with asthma and an allergy to penicillin who on 8/18/03 at 10:00 was vaccinated IM in the left arm with a second dose of hepatitis A virus vaccine inactivated (lot # 646368/0498N). Concomitant therapy included pirbuterol acetate inhalent. The patient was ill with asthma at the time of vaccination. On 8/18/03, the patient's mother called the medical office from home stating that the patient's opposite (unvaccinated) arm began shaking and the patient began to wheeze. The physician stated that the patient's right had and arm had tremors after leaving the immunization clinic. The reporting nurse directed the mother to take the patient to her physician. Unspecified medical attention was sought and no treatment was required. The reporter noted that the therapy was discontinued on 8/18/03. A product quality complaint was not involved. On 9/2/03, it was reported that the physician was called the following day and stated that the child was fine. The patient was having an asthma attack. The patient went to school with no problem. She did not have to go to a doctor, she just took medicine from her pirbuterol acetate inhalant. No further information is expected.
Patient states five minutes after vaccine administration both arms started "feeling funny." He attempted to shake them out and started feeling lightheaded. Patient denies any pain during this time. Remained awake and was assisted to observation area via wheelchair.
A report was received from a health care professional on 12Nov03, concerning an unspecified number of vaccinees under 4 years who have inadvertently received Fluvirin on unspecified date. On an unspecified date vaccinees under 4 years inadvertently received Fluvirin IM. The vaccinee did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporters causality assessment. Update 1, 07Jan04. A follow up report was received from a health care professional concerning a 2 year old male vaccine who inadvertently received Fluvirin on 07Nov03. On 07Nov03, the vaccinee inadvertently received Fluvirin. The vaccinee did not experienced any adverse symptoms at the time of reporting. No follow up pending, all information received. Multiple report cross reference with: PJP200301062, PJP200400063, PJP200400064, PJP200400065, PJP200400066, PJP200400067, PJP200400068, PJP200400069, PJP200400070, PJP200400071, PJP200400072, PJP200400073, PJP200400074, PJP200400075, PJP200400076, PJP200400078, PJP200400079.
6 days after receiving the COVID booster I started smelling cigarette smoke all over the place, then a week or so later I noticed little red dots across my stomach and arms then started tasting a metallic taste in my mouth.  4 weeks after my COVID booster I got my flu shot via my PCP.  1 week after on Weds I had a severe bloody nose that came and went over an 1.5 hours.  Then 2 days later on Friday I had another bloody nose.  Not as severe, but took about 20-30 mins to resolve.  On the following Monday the 6th I had a severe nose bleed that would not stop and blood was pouring out of my nose.  I had my neighbor take me to the ED.  My nose bleed stopped 1 hr and 15 mins after receiving the nasal medication.  It was a total of 3 hours after it started that it was under control.
The day after the shot, the arm developed a large raised, red, hot, painful welt, about the size of a plum, a couple inches below the injection site.  The welt remained painful for a week and gradually resolved on its own.  Patient (self) is unsure whether this indicates a future dose of this vaccine could be poorly tolerated.
This spontaneous report as received from a pharmacist refers to a newborn female patient of unknown age. On 27-OCT-2012 12:24, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified with lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
pt cried of shrill, high pitched cry for 7 hrs in PM date of shot; fever 103 R for 1 hr; treated w/APAP; leg red & swollen cold compresses; drank only 3 oz of formula all day; seen by MD;
Two weeks after shots. 2 red lines bout 0.5" across, one about 2" long, the other went down to the right, swelling around area. Diagnosed by provider as lymphangitis. Recovering